Invesco Ltd. Royalty Pharma PLC Transaction History
Invesco Ltd.
- $557 Billion
- Q2 2025
A detailed history of Invesco Ltd. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Invesco Ltd. holds 1,559,378 shares of RPRX stock, worth $55.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,559,378
Previous 1,284,418
21.41%
Holding current value
$55.9 Million
Previous $40 Million
40.52%
% of portfolio
0.01%
Previous 0.01%
Shares
21 transactions
Others Institutions Holding RPRX
# of Institutions
496Shares Held
306MCall Options Held
1.99MPut Options Held
384K-
Morgan Stanley New York, NY46.6MShares$1.67 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.4MShares$1.3 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$825 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA21.9MShares$785 Million0.14% of portfolio
-
Baillie Gifford & CO18MShares$646 Million0.51% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $15.7B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...